Timing of Erythropoiesis-Stimulating Agent Initiation and Adverse Outcomes in Nondialysis CKD: a Propensity-Matched Observational Study

Background and objectives: The severity of anemia at which to initiate erythropoiesis-stimulating agent (ESA) treatment in nondialysis chronic kidney disease (CKD) patients is unclear. Risk of mortality, hospitalizations, and blood transfusion were compared among nondialysis CKD patients with “early...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Seliger, Stephen, Fox, Kathleen M., Gandra, Shravanthi R., Bradbury, Brian, Hsu, Van Doren, Walker, Loreen, Chiou, Chiun-Fang, Fink, Jeffrey C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2010
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2863974/
https://ncbi.nlm.nih.gov/pubmed/20299377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07171009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados